Mutational analysis of the Hel-N1 gene in childhood acute lymphoblastic leukemia with LOH at 9p21
TO THE EDITOR Allelic loss of chromosome 9p21 is very common in childhood acute lymphoblastic leukemia (ALL), and inactivation of the tumor suppressor genes CDKN2a/INK4A/p16 and CDKN2b/INK4B/p15 is identified in most cases with chromosome 9p21 loss. We previously performed detailed deletional mapping of chromosome 9 using 54 childhood ALL samples and found that 14 of these samples had 9p21 loss without merase chain reaction (PCR-SSCP) analysis. The primer sequences and PCR conditions were reported previously. 3 The PCR products which are greater than 300 bp, were digested with appropriate restriction enzymes to yield a higher sensitivity. No mutations of Hel-N1 were found within the coding region of these ALL samples including those lacking a detectable CDKN2a/INK4A/p16 and CDKN2b/INK4B/p15 inactivation. Studies have shown that somatic mutations of the Hel-N1 gene have not been found in lung cancer samples, even though one of these had a localized homozygous deletion at D9S126. 4 We also identified one childhood ALL patient with a homozygous deletion at D9S126. 1 However, detailed mapping of the homozygous deletion revealed that it extended to the CDKN2a/INK4A/p16 gene. Homozygous deletion of the CDKN2a/INK4A/p16 gene in childhood ALL is very frequent. 2 Therefore, we could not conclude that the Hel-N1 is the primary target of homozygous deletion in this patient. These data suggest that Hel-N1 does not appear to be a primary inactivation target of 9p21 deletion in childhood ALL.
